Literature DB >> 1600265

Abnormalities of pulmonary function in patients with non-insulin-dependent diabetes mellitus.

H Mori1, M Okubo, M Okamura, K Yamane, S Kado, G Egusa, T Hiramoto, H Hara, M Yamakido.   

Abstract

To examine the possible association between the vascular complications of diabetes and changes in pulmonary function, we performed pulmonary function tests including assessment of the diffusing capacity (%DLco) in 80 patients with non-insulin-dependent diabetes mellitus (45 males and 35 females) without overt lung or heart disease. The mean age of the subjects was 57.9 years and the mean duration of diabetes was 10.8 years. The %DLco decreased significantly as the duration of diabetes increased (r = -0.38, p less than 0.01), and the same relationship was also observed in non-smoking subjects (N = 37). The reduction in %DLco was greater in patients with diabetic microangiopathy (especially nephropathy) and in those treated with insulin. Other pulmonary function tests (%VC, FEV1.0, PaO2 and PaCO2) showed no relationship to the duration of diabetes, the degree of microangiopathy or the type of treatment. These results suggest that diabetic microangiopathy may play an important role in the decrease of %DLco.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1600265     DOI: 10.2169/internalmedicine.31.189

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  9 in total

1.  Alveolar Gas Exchange and Pulmonary Functions in Patients with Type II Diabetes Mellitus.

Authors:  Anandhalakshmi S; Manikandan S; Ganeshkumar P; Ramachandran C
Journal:  J Clin Diagn Res       Date:  2013-08-28

Review 2.  The diabetic lung--a new target organ?

Authors:  Dario Pitocco; Leonello Fuso; Emanuele G Conte; Francesco Zaccardi; Carola Condoluci; Giuseppe Scavone; Raffaele A Incalzi; Giovanni Ghirlanda
Journal:  Rev Diabet Stud       Date:  2012-05-10

Review 3.  Normal expiratory flow rate and lung volumes in patients with combined emphysema and interstitial lung disease: a case series and literature review.

Authors:  Karen L Heathcote; Donald W Cockcroft; Derek A Fladeland; Mark E Fenton
Journal:  Can Respir J       Date:  2011 Sep-Oct       Impact factor: 2.409

Review 4.  When kidneys and lungs suffer together.

Authors:  Claudio Sorino; Nicola Scichilone; Claudio Pedone; Stefano Negri; Dina Visca; Antonio Spanevello
Journal:  J Nephrol       Date:  2018-12-06       Impact factor: 3.902

5.  Glycemic control influences lung membrane diffusion and oxygen saturation in exercise-trained subjects with type 1 diabetes: alveolar-capillary membrane conductance in type 1 diabetes.

Authors:  Courtney M Wheatley; James C Baldi; Nicholas A Cassuto; William T Foxx-Lupo; Eric M Snyder
Journal:  Eur J Appl Physiol       Date:  2010-10-10       Impact factor: 3.078

6.  Low total haemoglobin mass, blood volume and aerobic capacity in men with type 1 diabetes.

Authors:  Anne S Koponen; Juha E Peltonen; Marja K Päivinen; Jyrki M Aho; Harriet J Hägglund; Arja L Uusitalo; Harri J Lindholm; Heikki O Tikkanen
Journal:  Eur J Appl Physiol       Date:  2012-11-06       Impact factor: 3.078

7.  Associations of measures of lung function with insulin resistance and Type 2 diabetes: findings from the British Women's Heart and Health Study.

Authors:  D A Lawlor; S Ebrahim; G Davey Smith
Journal:  Diabetologia       Date:  2003-12-24       Impact factor: 10.122

8.  Pulmonary function tests in type 2 diabetes mellitus and their association with glycemic control and duration of the disease.

Authors:  Swati H Shah; Pranali Sonawane; Pradeep Nahar; Savita Vaidya; Sundeep Salvi
Journal:  Lung India       Date:  2013-04

9.  Diabetes and lung cancer among postmenopausal women.

Authors:  Juhua Luo; Rowan Chlebowski; Jean Wactawski-Wende; Nicolas F Schlecht; Lesley Tinker; Karen L Margolis
Journal:  Diabetes Care       Date:  2012-05-22       Impact factor: 19.112

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.